Expression of Osterix in mechanical stress-induced osteogenic differentiation of periodontal ligament cells in vitro.

PubWeight™: 0.85‹?›

🔗 View Article (PMID 18471237)

Published in Eur J Oral Sci on June 01, 2008

Authors

Yanhong Zhao1, Chunling Wang, Shu Li, Hui Song, Fulan Wei, Keqing Pan, Kun Zhu, Pishan Yang, Qisheng Tu, Jake Chen

Author Affiliations

1: School of Stomatology, Shandong University, Jinan, Shandong, China.

Articles by these authors

The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation. Immunity (2008) 7.60

Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet (2012) 5.48

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1). Lancet (2008) 5.32

DisProt: the Database of Disordered Proteins. Nucleic Acids Res (2006) 4.46

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2). Lancet (2008) 4.06

Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial. Lancet (2005) 3.59

Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial. Lancet (2009) 3.55

Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial. Lancet (2013) 3.18

Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis. N Engl J Med (2010) 2.74

Recruitment of Atg9 to the preautophagosomal structure by Atg11 is essential for selective autophagy in budding yeast. J Cell Biol (2006) 2.35

Silk implants for the healing of critical size bone defects. Bone (2005) 2.22

Calcium supplementation and the risks of atherosclerotic vascular disease in older women: results of a 5-year RCT and a 4.5-year follow-up. J Bone Miner Res (2011) 2.08

The effects of 3 years of calcium supplementation on common carotid artery intimal medial thickness and carotid atherosclerosis in older women: an ancillary study of the CAIFOS randomized controlled trial. J Bone Miner Res (2014) 2.08

A genome-wide association study in Han Chinese identifies new susceptibility loci for ankylosing spondylitis. Nat Genet (2011) 2.05

School-milk intervention trial enhances growth and bone mineral accretion in Chinese girls aged 10-12 years in Beijing. Br J Nutr (2004) 1.88

Disorder and sequence repeats in hub proteins and their implications for network evolution. J Proteome Res (2006) 1.87

Habitual chocolate intake and vascular disease: a prospective study of clinical outcomes in older women. Arch Intern Med (2010) 1.83

Ustekinumab, an anti-IL-12/23 p40 monoclonal antibody, inhibits radiographic progression in patients with active psoriatic arthritis: results of an integrated analysis of radiographic data from the phase 3, multicentre, randomised, double-blind, placebo-controlled PSUMMIT-1 and PSUMMIT-2 trials. Ann Rheum Dis (2014) 1.80

Porous silk fibroin 3-D scaffolds for delivery of bone morphogenetic protein-2 in vitro and in vivo. J Biomed Mater Res A (2006) 1.68

Infliximab induction therapy for patients with severe plaque-type psoriasis: a randomized, double-blind, placebo-controlled trial. J Am Acad Dermatol (2004) 1.66

Acute diarrhea in West African children: diverse enteric viruses and a novel parvovirus genus. J Virol (2012) 1.64

Optimal structure requirements for pluronic block copolymers in modifying P-glycoprotein drug efflux transporter activity in bovine brain microvessel endothelial cells. J Pharmacol Exp Ther (2003) 1.61

A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis. J Am Acad Dermatol (2006) 1.59

Assessment of gene-by-sex interaction effect on bone mineral density. J Bone Miner Res (2012) 1.58

A comparison of safety, tolerability and immunogenicity of Oka/Merck varicella vaccine and VARILRIX in healthy children. Vaccine (2002) 1.56

In vivo reconstitution of autophagy in Saccharomyces cerevisiae. J Cell Biol (2008) 1.48

Allogeneic periodontal ligament stem cell therapy for periodontitis in swine. Stem Cells (2010) 1.40

Data mining in bioinformatics: selected papers from BIOKDD. IEEE/ACM Trans Comput Biol Bioinform (2010) 1.39

A macrophage-nanozyme delivery system for Parkinson's disease. Bioconjug Chem (2007) 1.38

A third gyrovirus species in human faeces. J Gen Virol (2012) 1.36

Effects of miR-335-5p in modulating osteogenic differentiation by specifically downregulating Wnt antagonist DKK1. J Bone Miner Res (2011) 1.35

Negative regulation of MDA5- but not RIG-I-mediated innate antiviral signaling by the dihydroxyacetone kinase. Proc Natl Acad Sci U S A (2007) 1.35

Prediction of antimicrobial peptides based on sequence alignment and feature selection methods. PLoS One (2011) 1.34

Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial. Ann Rheum Dis (2014) 1.33

Use of statistical models for evaluating antibody response as a correlate of protection against varicella. Stat Med (2002) 1.32

Low vitamin D status has an adverse influence on bone mass, bone turnover, and muscle strength in Chinese adolescent girls. J Nutr (2009) 1.30

Mandibular repair in rats with premineralized silk scaffolds and BMP-2-modified bMSCs. Biomaterials (2009) 1.29

SENP2 negatively regulates cellular antiviral response by deSUMOylating IRF3 and conditioning it for ubiquitination and degradation. J Mol Cell Biol (2011) 1.28

BSP and RANKL induce osteoclastogenesis and bone resorption synergistically. J Bone Miner Res (2005) 1.26

Virus-triggered ubiquitination of TRAF3/6 by cIAP1/2 is essential for induction of interferon-beta (IFN-beta) and cellular antiviral response. J Biol Chem (2010) 1.25

Effects of ergocalciferol added to calcium on the risk of falls in elderly high-risk women. Arch Intern Med (2008) 1.25

Calcium-sensing receptor activation of rho involves filamin and rho-guanine nucleotide exchange factor. Endocrinology (2002) 1.24

Osterix enhances proliferation and osteogenic potential of bone marrow stromal cells. Biochem Biophys Res Commun (2006) 1.21

Direct interaction between two viral proteins, the nonstructural protein 2C and the capsid protein VP3, is required for enterovirus morphogenesis. PLoS Pathog (2010) 1.20

Overexpression of Phex in osteoblasts fails to rescue the Hyp mouse phenotype. J Biol Chem (2001) 1.20

Genomic and proteomic analyses of the terminally redundant genome of the Pseudomonas aeruginosa phage PaP1: establishment of genus PaP1-like phages. PLoS One (2013) 1.20

Sensitization of cells overexpressing multidrug-resistant proteins by pluronic P85. Pharm Res (2003) 1.17

Neural mechanism of intertemporal choice: from discounting future gains to future losses. Brain Res (2009) 1.17

Pluronic block copolymers alter apoptotic signal transduction of doxorubicin in drug-resistant cancer cells. J Control Release (2005) 1.16

Doubly amphiphilic poly(2-oxazoline)s as high-capacity delivery systems for hydrophobic drugs. Biomaterials (2010) 1.16

Osterix overexpression in mesenchymal stem cells stimulates healing of critical-sized defects in murine calvarial bone. Tissue Eng (2007) 1.14

A 5-year cohort study of the effects of high protein intake on lean mass and BMC in elderly postmenopausal women. J Bone Miner Res (2009) 1.14

Effects of three-monthly oral 150,000 IU cholecalciferol supplementation on falls, mobility, and muscle strength in older postmenopausal women: a randomized controlled trial. J Bone Miner Res (2012) 1.13

Macrophage delivery of therapeutic nanozymes in a murine model of Parkinson's disease. Nanomedicine (Lond) (2010) 1.12

The viruses of wild pigeon droppings. PLoS One (2013) 1.12

Computer access to research on dietary supplements: a database of federally funded dietary supplement research. J Nutr (2005) 1.12

Application of induced pluripotent stem (iPS) cells in periodontal tissue regeneration. J Cell Physiol (2011) 1.12

PqsD is responsible for the synthesis of 2,4-dihydroxyquinoline, an extracellular metabolite produced by Pseudomonas aeruginosa. J Biol Chem (2008) 1.11

Differential metabolic responses to pluronic in MDR and non-MDR cells: a novel pathway for chemosensitization of drug resistant cancers. J Control Release (2009) 1.11

A Pseudomonas aeruginosa transcription factor that senses fatty acid structure. Mol Microbiol (2007) 1.10

Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year. J Am Acad Dermatol (2007) 1.10

Efficacy and safety of ustekinumab for the treatment of moderate-to-severe psoriasis: a phase III, randomized, placebo-controlled trial in Taiwanese and Korean patients (PEARL). J Dermatol Sci (2011) 1.10

Epithelial junction opener JO-1 improves monoclonal antibody therapy of cancer. Cancer Res (2011) 1.09

Distribution kinetics of a micelle-forming block copolymer Pluronic P85. J Control Release (2004) 1.09

Effect of large incisor retraction on upper airway morphology in adult bimaxillary protrusion patients. Angle Orthod (2012) 1.09

Monomeric sarcosine oxidase: role of histidine 269 in catalysis. Biochemistry (2002) 1.08

Gingiva-derived mesenchymal stem cell-mediated therapeutic approach for bone tissue regeneration. Stem Cells Dev (2011) 1.08

WDR5 is essential for assembly of the VISA-associated signaling complex and virus-triggered IRF3 and NF-kappaB activation. Proc Natl Acad Sci U S A (2009) 1.08

Adiponectin inhibits osteoclastogenesis and bone resorption via APPL1-mediated suppression of Akt1. J Biol Chem (2011) 1.08

Infliximab monotherapy provides rapid and sustained benefit for plaque-type psoriasis. J Am Acad Dermatol (2003) 1.08

Adverse events from calcium supplementation: relationship to errors in myocardial infarction self-reporting in randomized controlled trials of calcium supplementation. J Bone Miner Res (2012) 1.07

Effect of pluronic P85 on ATPase activity of drug efflux transporters. Pharm Res (2004) 1.07

Critical-size calvarial bone defects healing in a mouse model with silk scaffolds and SATB2-modified iPSCs. Biomaterials (2011) 1.07

HIF-1 alpha signaling is augmented during intermittent hypoxia by induction of the Nrf2 pathway in NOX1-expressing adenocarcinoma A549 cells. Free Radic Biol Med (2010) 1.06

The use of injectable sonication-induced silk hydrogel for VEGF(165) and BMP-2 delivery for elevation of the maxillary sinus floor. Biomaterials (2011) 1.05

Alteration of genomic responses to doxorubicin and prevention of MDR in breast cancer cells by a polymer excipient: pluronic P85. Mol Pharm (2006) 1.05

Influence of CYP4F2 genotype on warfarin dose requirement-a systematic review and meta-analysis. Thromb Res (2011) 1.05

Overexpression of bone sialoprotein leads to an uncoupling of bone formation and bone resorption in mice. J Bone Miner Res (2008) 1.04

Balancing the funds in the New Cooperative Medical Scheme in rural China: determinants and influencing factors in two provinces. Int J Health Plann Manage (2010) 1.04

Apatite-coated silk fibroin scaffolds to healing mandibular border defects in canines. Bone (2009) 1.03

Effects of pluronic and doxorubicin on drug uptake, cellular metabolism, apoptosis and tumor inhibition in animal models of MDR cancers. J Control Release (2010) 1.03

Coadministration of epithelial junction opener JO-1 improves the efficacy and safety of chemotherapeutic drugs. Clin Cancer Res (2012) 1.03

Mixed polymer micelles of amphiphilic and cationic copolymers for delivery of antisense oligonucleotides. J Drug Target (2004) 1.02

An in vivo model to study osteogenic gene regulation: targeting an avian retroviral receptor (TVA) to bone with the bone sialoprotein (BSP) promoter. J Bone Miner Res (2005) 1.02

Genetic determinants of heel bone properties: genome-wide association meta-analysis and replication in the GEFOS/GENOMOS consortium. Hum Mol Genet (2014) 1.02

Association between yogurt, milk, and cheese consumption and common carotid artery intima-media thickness and cardiovascular disease risk factors in elderly women. Am J Clin Nutr (2011) 1.02

The effects of aqueous extracts prepared from the leaves of Pistacia lentiscus in experimental liver disease. J Ethnopharmacol (2005) 1.02

Transcriptional upregulation of breast cancer resistance protein by 17beta-estradiol in ERalpha-positive MCF-7 breast cancer cells. Oncology (2007) 1.01

FabH selectivity for anteiso branched-chain fatty acid precursors in low-temperature adaptation in Listeria monocytogenes. FEMS Microbiol Lett (2009) 1.00

A new human DSG2-transgenic mouse model for studying the tropism and pathology of human adenoviruses. J Virol (2012) 1.00

Polyelectrolyte complex optimization for macrophage delivery of redox enzyme nanoparticles. Nanomedicine (Lond) (2011) 0.99